New study supports remdesivir as COVID-19 treatment

July 9, 2020
Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.

Seven new Gillings Innovation Labs will tackle COVID-19

July 6, 2020
Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.

Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians

July 6, 2020
A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.

Giving a global voice to minority smoking inequities

June 22, 2020
A UNC-Chapel Hill student-led public health team places third among 3,500 participants in Oxford University’s global systems mapping competition, exploring racial and ethnic disparities in tobacco control.

Gillings alumnus Handzel named CDC’s global water, sanitation and hygiene coordinator

June 15, 2020
The United States Centers for Disease Control and Prevention (CDC) recently appointed UNC Gillings School alumnus Dr. Tom Handzel as global WASH coordinator at their Center for Global Health. (WASH stands for Water, Sanitation and Hygiene.)

UNC-Chapel Hill researchers create new type of COVID-19 antibody test

June 15, 2020
Scientists have created a test that pinpoints human antibodies specific to a unique part of the SARS-CoV-2 spike protein. The test can help document COVID-19 infections, identify asymptomatic virus infection and measure the level of immunity in individuals.

Researchers map how coronavirus infection travels through cells of nasal cavity and respiratory tract

June 2, 2020
A major study of novel coronavirus infection in human airways adds to evidence that wearing a mask is an important step toward limiting transmission of COVID-19. The lead authors of the study in the journal Cell are UNC-Chapel Hill virology expert Dr. Ralph Baric and pulmonary expert Dr. Richard Boucher.

‘Landmark’ study finds long-acting injectable drug highly effective in preventing HIV

June 1, 2020
A large-scale HIV study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, showed higher efficacy than a daily oral pill.

The Gillings Community Responds to COVID-19: Global Outreach

June 1, 2020
The novel coronavirus pandemic has created and magnified health challenges on a global scale. In Africa, alumni Michael Wilson and Dr. Laura Hoemeke are working on both a grassroots and a policy level to protect communities and health care services that are most vulnerable.

Gillings researchers advance in the quest for a dengue vaccine

May 13, 2020
Dengue viruses are estimated to cause ~390 million infections and 100 million cases each year around the globe. Because infection with one of the four unique dengue strains does not provide lasting immunity to the other strains, it has been especially difficult to create an effective vaccine.

Visit our communications and marketing team page.
Contact with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400